Science Explorer Back to mapMap
Discussion
Researcher · Q Therapeutics (United States) · United States

Hugh Gannon

Hugh Gannon publishes mostly in Molecular Biology, Oncology and Cancer Research, on topics such as CRISPR and Genetic Engineering, DNA Repair Mechanisms and Cancer-related Molecular Pathways.

ORCID 0000-0003-0923-7330 OpenAlex
World rank
#1,234,760
of 7,710,434 ranked researchers
Rank in United States
#394,905
of 1,627,098
Works
61
Citations
1.4k
Citations per work
23.1
h-index
12
i10-index 12Top 65% in Molecular Biology
Hugh Gannon

What does Hugh Gannon research?

Hugh Gannon's work is mostly in Biochemistry, Genetics and Molecular Biology (63%), Medicine (26%), Immunology and Microbiology (3%).

Life Sciences: 40 works · 65.4% of their workBiochemistry, Genetics and Molecular Biology: 38 works · 62.8% of their workMolecular Biology: 31 works · 51.3% of their workCancer Research: 4 works · 6.4% of their workBiotechnology: 3 works · 5.1% of their workImmunology and Microbiology: 2 works · 2.6% of their workImmunology: 2 works · 2.6% of their workHealth Sciences: 16 works · 25.6% of their workMedicine: 16 works · 25.6% of their workOncology: 13 works · 21.8% of their workRadiology, Nuclear Medicine and Imaging: 2 works · 3.8% of their workEverything else: 5 works · 9.0% of their workTHEIR WORKHugh Gannon61works
Life Sciences65%Health Sciences26%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology3862.8%
    2. Immunology and Microbiology22.6%
    1. Medicine1625.6%
  3. Everything else59.0%
  1. 1Molecular Biology51% of their works
  2. 2Oncology22% of their works
  3. 3Cancer Research6% of their works
  4. 4Biotechnology5% of their works
  5. 5Radiology, Nuclear Medicine and Imaging4% of their works
  6. 6Immunology3% of their works

Research topics

Which keywords describe Hugh Gannon's research?

The keywords of their largest research topics: Genome Engineering, Homologous Recombination, Immunotherapy, RNA-Guided, Tumor Regression, Cancer Therapy, DNA Damage and Repair.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Genome Engineering101 topic
  2. Homologous Recombination102 topics
  3. Immunotherapy102 topics
  4. RNA-Guided101 topic
  5. Tumor Regression102 topics
  6. Cancer Therapy92 topics
  7. DNA Damage71 topic
  8. Repair71 topic
  9. CAR T Cells61 topic
  10. Cell Cycle61 topic
  11. Chimeric Antigen Receptor61 topic
  12. p5361 topic
  13. Bacterial Therapy41 topic
  14. Tumor Targeting41 topic
  15. BRCA Mutation31 topic
  16. DNA Methylation31 topic
  17. Histone Modification31 topic
  18. PARP Inhibitors31 topic
  19. HIF-121 topic
  20. Warburg Effect21 topic

Where does Hugh Gannon work?

Hugh Gannon's main affiliation in the publication record is Q Therapeutics (United States), United States.

How many publications and citations does Hugh Gannon have?

OpenAlex counts 61 works and 1,412 citations for Hugh Gannon, an h-index of 12, ranking #1,234,760 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Hugh Gannon. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.